Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on February 25
RAMAT GAN, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing...
COVID-19
Tilray Brands Enhances Global Cannabis Supply Chain
Tilray Increases Industry-Leading Capacity to Meet Global Demand, Driving Growth Across Canada and EuropeNEW YORK and LEAMINGTON, Ontario, Feb. 10,...
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference
Two presentations at ISC build on a growing body of data demonstrating the value of AI-powered portable MR images in...
AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks
Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of...
Hernando Ruiz-Jimenez assumes chief marketing and communications officer role at Geisinger
DANVILLE, Pa., Feb. 6, 2025 /PRNewswire/ -- Hernando Ruiz-Jimenez is Geisinger's new chief marketing and communications officer, a role in which...
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
WEXFORD, Pa., Feb. 6, 2025 /PRNewswire/ -- COEPTIS, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a pioneering technology company dedicated...
Universal Technical Institute Reports Fiscal Year 2025 First Quarter Results
Delivers Financial and Operational Outperformance in Fiscal Q1; Raises Fiscal 2025 Guidance Ranges for All Metrics PHOENIX, Feb. 5, 2025...
FM:Systems Study Finds 81% of Business Leaders Have Reached or Are Nearing a “New Normal” Five Years After COVID-19, Balancing Business Priorities and Employee Needs
FM:Systems 2025 Inside the Workplace Report Highlights: 76% of organizations are preparing to deploy generative artificial intelligence (GenAI) and 46%...
Erasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
Safety Committee approval based on positive Phase 1 safety data demonstrating the combination therapy to be generally well-tolerated with no...
Celebrating the Winners of the Inaugural Sony Women in Technology Award with Nature
NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ -- Sony Group Corporation (Sony) and Nature are proud...
CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares
Calgary, Alberta--(Newsfile Corp. - February 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
Rural healthcare leaders prioritize cybersecurity, revenue optimization and AI investments
Optimism grows as rural healthcare organizations adapt to post-pandemic challenges MILWAUKEE, Feb. 4, 2025 /PRNewswire/ -- Wipfli, a top 25...
Catheter Precision, Inc. Announces The Closing of its Acquisition of PeriKard, LLC
FORT MILL, S.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device...
Hemostemix Expands to the Dominican Republic
Calgary, Alberta--(Newsfile Corp. - February 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025
US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex...
Pharmacy Increases Revenue 52% for Vaccine Delivery Using Workflow Services
Medical billing platform has streamlined patient encounters by automating claim submissions and resolving issues with payors, new case study shows...
Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill
SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Rebranding Signals Strategic Shift Beyond Biopharmaceuticals, Highlights Commitment to Technology, Artificial Intelligence and Shareholder Value WEXFORD, Pa., Jan. 30, 2025...
Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications
Cognizant will provide AI-driven solutions to enhance customer service, employee engagement, and business value TEANECK, N.J., Jan. 30, 2025 /PRNewswire/...
Hemostemix Announces First Sales Orders for ACP-01
Calgary, Alberta--(Newsfile Corp. - January 29, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...